Clinical Trials Map

The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but figuring out how to participate in psychedelic-assisted therapy as either a therapist or a patient can be complicated. BCSP’s clinical trials map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing and future trials.

Status Substance Study Location(s)
closed

Trifecta Research Study

Axial Therapeutic ResearchNorthridge, California, United States

openPsilocybin

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer’s Disease

Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States

openPsilocybin

Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

NYU Langone HealthNew York, New York, United States

openPsilocybin

Subjective Experience Following Psilocybin

University of CalgaryCalgary, Alberta, Canada

openPsilocybin

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

UC San DiegoSan Diego, California, United States

openPsilocybin

MB-PAT for Demoralization in Advanced Cancer (‘PAT-MIND’) Trial

Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada

Providence Care HospitalKingston, Ontario, Canada

open

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

UAB Psychiatry and Behavioral NeurologyBirmingham, Alabama, United States

Lighthouse PsychiatryGilbert, Arizona, United States

Pillar Clinical Research – Little RockLittle Rock, Arkansas, United States

Behavioral Research Specialists, LLCGlendale, California, United States

Sun Valley Research CenterImperial, California, United States

CalNeuro Research GroupLos Angeles, California, United States

ATP Clinical ResearchOrange, California, United States

NRC Research InstituteOrange, California, United States

Inland Psychiatric Medical Group Inc (IPMG Research)San Juan Capistrano, California, United States

Psychedelic Science InstituteSanta Monica, California, United States

Stanford UniversityStanford, California, United States

Yale School of Medicine – Yale Program for Psychedelic ScienceNew Haven, Connecticut, United States

CNS HealthcareJacksonville, Florida, United States

Accel Research Sites – MaitlandMaitland, Florida, United States

Aqualane Clinical ResearchNaples, Florida, United States

Emory University Dept of Psychiatry and Behavioral StudiesAtlanta, Georgia, United States

Psych AtlantaMarietta, Georgia, United States

Rush UniversityChicago, Illinois, United States

Tandem Clinical ResearchMarrero, Louisiana, United States

Atlas PsychiatryNew Orleans, Louisiana, United States

Johns Hopkins MedicineBaltimore, Maryland, United States

Institute for Integrative TherapiesEden Prairie, Minnesota, United States

Redbird Research, LLCLas Vegas, Nevada, United States

Bio Behavioral HealthToms River, New Jersey, United States

New York State Psychiatric InstituteNew York, New York, United States

SP Research PLLCOklahoma City, Oklahoma, United States

Adams Clinical PhiladelphiaPhiladelphia, Pennsylvania, United States

Flourish Research PhiladelphiaPhiladelphia, Pennsylvania, United States

Austin Clinical Trial PartnersAustin, Texas, United States

North Texas Clinical TrialsFort Worth, Texas, United States

Brain Health Consultants and TMS CenterHouston, Texas, United States

Flourish Research San AntonioSan Antonio, Texas, United States

Core Clinical ResearchEverett, Washington, United States

Seattle Neuropsychiatric Treatment CenterSeattle, Washington, United States

Royal Prince Alfred HospitalCamperdown, New South Wales, Australia

Thompson Brain & Mind Healthcare (TBMH)Maroochydore, Queensland, Australia

Ramsay ClinicMelbourne, Victoria, Australia

Neurocentrix ResearchMelbourne, Victoria, Australia

Monash University – Notting HillNotting Hill, Victoria, Australia

Institute of neuropsychiatric Care (INEP)Prague, Czechia

Psyon s.r.o.Prague, Czechia

A-SHINE s.r.o.Předměstí, Czechia

Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des SaarlandesHomburg, Saarland, Germany

Charité Universitaetsmedizin BerlinBerlin, Germany

University Hospital FrankfurtFrankfurt am Main, Germany

Central Institute of Mental HealthMannheim, Germany

Eginitio HospitalAthens, Greece

Attikon University HospitalAthens, Greece

Papageorgiou General HospitalThessaloniki, Greece

Sheaf House – Tallaght Adult Mental Health ServiceDublin, Ireland

La Nua Day Hospital Mental Health CentreGalway, Ireland

Uniwersytecki Szpital Kliniczny W BiałymstokuBialystok, Poland

Promente – Centrum Neurologii i Psychogeriatrii w BydgoszczyBydgoszcz, Poland

UCKGdansk, Poland

Centrum Badan Klinicznych PI-House Sp. z o.oGdansk, Poland

MTZ Clinical Research Powered by PratiaWarsaw, Poland

Department of Pharmacology and Physiology of CNSWarsaw, Poland

Cambridge University Hospital NHSCambridge, United Kingdom

Clerkenwell Health – DoncasterDoncaster, United Kingdom

NHS Research ScotlandEdinburgh, United Kingdom

Queen Elizabeth University HospitalGlasgow, United Kingdom

St Pancras Clinical ResearchLondon, United Kingdom

King's College LondonLondon, United Kingdom

Clerkenwell Health – Welbeck StreetLondon, United Kingdom

Re:Cognition HealthLondon, United Kingdom

Clerkenwell Health – Baker StreetLondon, United Kingdom

Edwardson Building – Campus for Ageing and VitalityNewcastle upon Tyne, United Kingdom

Ascend Clinical ResearchReading, United Kingdom

Sheffield Health and Social Care NHS Foundation TrustSheffield, United Kingdom

openPsilocybin

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

Toronto Western Hospital (University Health Network)Toronto, Ontario, Canada

Centre for Addiction and Mental HealthToronto, Ontario, Canada

closed

Psychedelic Virtual Reality

Yale University School of MedicineNew Haven, Connecticut, United States

openPsilocybin

Psilocybin for Methamphetamine Use Disorder

University of Alabama at BirminghamBirmingham, Alabama, United States

Page 1 of 18

Filters
Clear Filters
Open
Closed
Sex
Age

How to use the clinical trials map

Clinical trials have provided growing evidence that ketamine, psilocybin, and MDMA can work in combination with therapy to help alleviate a range of mental disorders, including PTSD, depression, substance-use disorders, and anxiety. The field is advancing rapidly, but it can be difficult to navigate changing information to learn more about specific trials. 

In the map view, explore clinical trials based on location. Click on a pink cluster or use the + button to zoom in on a particular location. Click on a smaller pink dot to access an overview of a particular clinical trial, including the substance, the phase, and relevant conditions. Click on the “Full Trial Record” link to learn more about the trial on the ClinicalTrials.gov site.

In the list view, the clinical trials tracker offers a tool for researchers and clinicians to quantify and explore trials based on a number of factors. Click on “Filter” to see relevant trials based on substance, trial status, study phase and more. Where the list shows closed trials users are able explore published results, including searching by institution.

Learn more about clinical trials and how they work here.

Subscribe to news from the BCSP

A monthly email featuring our news, research, programs, and events.